Astral Limited Acquires 80% Stake in NEXELON, Enters CPVC Resin Manufacturing
Astral Limited is acquiring an 80% stake in NEXELON CHEM PRIVATE LIMITED for Rs. 80,000, with plans to invest up to Rs. 120 crores. This strategic move marks Astral's entry into CPVC resin production, a key raw material for its pipe manufacturing business. The acquisition aims to optimize costs, improve margins, and ensure quality control. The facility will have an annual production capacity of 40,000 M.T. of CPVC Resin, with commercial production expected to start by Q2 FY-27. This vertical integration comes amid challenges in the polymer industry, including weak demand and price volatility.

*this image is generated using AI for illustrative purposes only.
Astral Limited , a pioneer in CPVC pipes and fittings manufacturing, has announced a strategic move to vertically integrate its operations by acquiring an 80% stake in NEXELON CHEM PRIVATE LIMITED, a chemical manufacturing company. This acquisition marks Astral's entry into the production of CPVC resin, a crucial raw material for its core business.
Acquisition Details
The Board of Directors of Astral Limited approved the acquisition of an 80% equity stake in NEXELON CHEM PRIVATE LIMITED for an initial cash consideration of Rs. 80,000 at par value. The company plans to invest up to Rs. 120.00 crores over time, with the total project cost estimated at Rs. 150.00 crores.
Strategic Importance
This move into backward integration is expected to bring significant benefits to Astral:
- Cost Optimization: By manufacturing its own CPVC resin, Astral aims to reduce production costs substantially.
- Margin Improvement: The company anticipates a notable enhancement in profit margins due to this vertical integration.
- Quality Control: Astral reports that its CPVC resin quality is on par with international standards, ensuring consistent quality for its products.
Project Timeline and Capacity
- Completion: The transaction is expected to be finalized within 2-3 months, with the capital structure to be determined in the next 60 days.
- Production Capacity: The facility is planned to manufacture 40,000 M.T. of CPVC Resin annually.
- Commercial Production: Astral aims to commence commercial production by Q2 FY-27.
About NEXELON CHEM PRIVATE LIMITED
NEXELON, incorporated in July 2023, specializes in the manufacturing of chemicals and chemical products, with a focus on CPVC resin production. The company is currently in the process of setting up its manufacturing unit and has not yet begun revenue generation.
Industry Context
This acquisition comes at a time when the polymer industry has been facing challenges:
- Q1 Performance: Astral reported a weak demand scenario in the polymer industry during this quarter.
- Price Volatility: The company experienced volatile polymer prices, with average PVC prices dropping approximately 14% year-over-year in Q1.
- Market Improvement: However, Astral notes that from the beginning of Q2, PVC prices are stabilizing, which is expected to help in achieving better realization and improving demand.
Financial Highlights
While the acquisition news takes center stage, Astral's recent financial performance provides context:
Metric | Value (in million) | % of Net Sales |
---|---|---|
Revenue | 13,612.00 | - |
EBITDA | 1,940.00 | 14.30% |
PAT | 792.00 | 5.80% |
Outlook
Astral's move into CPVC resin manufacturing represents a significant step in its growth strategy. By securing control over a key raw material, the company is positioning itself for improved cost efficiency and potentially higher profitability in the coming years. As the polymer market shows signs of stabilization, this vertical integration could prove to be a timely strategic decision for Astral Limited.
Historical Stock Returns for Astral
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
+0.42% | -3.28% | -6.34% | -2.37% | -28.71% | +125.36% |